Adds: Surgery Partners, Nuveen; Updates: Eli Lilly
June 17 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Tuesday:
** Surgery Partners <SGRY.O> said it was unable to agree to the terms set by Bain Capital, its largest shareholder, to take the surgical facility operator private. nL4N3SK0YM
** Eli Lilly <LLY.N> will acquire gene-editing startup Verve Therapeutics <VERV.O> for up to $1.3 billion, the companies said, to boost its pipeline of experimental medicines beyond its blockbuster weight-loss and diabetes drugs. nL4N3SJ1JV
** Nuveen said it is acquiring Brooklyn Investment Group and its parent technology company, as the asset manager looks to expand its footprint in direct indexing, a fast-growing area of the investment management industry. nL4N3SJ1IU
** London-listed venture capital investor BP Marsh has acquired a 27% shareholding in Cameron Specialty, a London-based specialty MGA. nL6N3SK0DF
** Private equity firm KKR <KKR.N> said it had agreed to acquire Australian power producer Zenith Energy from a consortium comprising Australia-based Pacific Equity Partners, Canada's OPSEU Pension Trust and London-listed Foresight Group <FSGF.L>. nL4N3SJ1GP
(Compiled by Rajarshi Roy and Padmanabhan Ananthan in Bengaluru)
((Padmanabhan.Ananthan@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。